Rabdosia japonicavar.glaucocalyxFlavonoids Fraction Attenuates Lipopolysaccharide‐Induced Acute Lung Injury in Mice
Open Access
- 1 January 2014
- journal article
- research article
- Published by Wiley in Evidence-Based Complementary and Alternative Medicine
- Vol. 2014 (1) , 894515
Abstract
Rabdosia japonicavar.glaucocalyx(Maxim.) Hara, belonging to theLabiataefamily, is widely used as an anti‐inflammatory and antitumor drug for the treatment of different inflammations and cancers.Aim of the Study. To investigate therapeutic effects and possible mechanism of the flavonoids fraction ofRabdosia japonicavar.glaucocalyx(Maxim.) Hara (RJFs) in acute lung injury (ALI) mice induced by lipopolysaccharide (LPS).Materials and Methods. Mice were orally administrated with RJFs (6.4, 12.8, and 25.6 mg/kg) per day for 7 days, consecutively, before LPS challenge. Lung specimens and the bronchoalveolar lavage fluid (BALF) were isolated for histopathological examinations and biochemical analysis. The level of complement 3 (C3) in serum was quantified by a sandwich ELISA kit.Results. RJFs significantly attenuated LPS‐induced ALI via reducing productions of the level of inflammatory mediators (TNF‐α, IL‐6, and IL‐1β), and significantly reduced complement deposition with decreasing the level of C3 in serum, which was exhibited together with the lowered myeloperoxidase (MPO) activity and nitric oxide (NO) and protein concentration in BALF.Conclusions. RJFs significantly attenuate LPS‐induced ALIviareducing productions of proinflammatory mediators, decreasing the level of complement, and reducing radicals.Keywords
Funding Information
- Hong Kong Baptist University (10KJB350004, SYS201206)
- Natural Science Fund for Colleges and Universities in Jiangsu Province (10KJB350004, SYS201206)
- Suzhou Application Foundation Research Project (10KJB350004, SYS201206)
- Priority Academic Program Development of Jiangsu Higher Education Institutions (10KJB350004, SYS201206)
This publication has 38 references indexed in Scilit:
- Complement 3 is involved with ventilator-induced lung injuryInternational Immunopharmacology, 2011
- Luteolin Suppresses Inflammatory Mediator Expression by Blocking the Akt/NFκB Pathway in Acute Lung Injury Induced by Lipopolysaccharide in MiceEvidence-Based Complementary and Alternative Medicine, 2011
- Role of C3, C5 and Anaphylatoxin Receptors in Acute Lung Injury and in Sepsis2011
- Exacerbated brain damage, edema and inflammation in type-2 diabetic mice subjected to focal ischemiaJournal of Neurochemistry, 2010
- The resolution of inflammation: Anti-inflammatory roles for NF-κBThe International Journal of Biochemistry & Cell Biology, 2010
- BERBERINE INHIBITS CYTOSOLIC PHOSPHOLIPASE A2 AND PROTECTS AGAINST LPS-INDUCED LUNG INJURY AND LETHALITY INDEPENDENT OF THE α2-ADRENERGIC RECEPTOR IN MICEShock, 2008
- LOCAL STIMULATION OF α7 CHOLINERGIC RECEPTORS INHIBITS LPS-INDUCED TNF-α RELEASE IN THE MOUSE LUNGShock, 2007
- Statins and sepsis: multiple modifications at multiple levelsThe Lancet Infectious Diseases, 2007
- Regeneration of the endothelium as a novel therapeutic strategy for acute lung injuryJournal of Clinical Investigation, 2006
- An in vivo hamster bioassay to assess the toxicity of particulates for the lungsToxicology and Applied Pharmacology, 1982